secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001558370-24-007348
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta Q2 revenue $159M (+7%); non-GAAP EPS $0.05; $111M goodwill impairment; guides FY rev lower
--------------------------------------------------------------------------------

- Revenue $159M, up 7% YoY; organic growth 7%; B Medical revenue up 51% to $23M.
- GAAP diluted EPS from continuing ops ($2.47) vs ($0.03); includes $111.3M non-cash goodwill impairment in B Medical.
- Non-GAAP diluted EPS $0.05 vs ($0.06); adjusted EBITDA $9M vs ($2M); margin 5.9% up 750 bps.
- FY2024 rev guidance lowered to $659-$671M (organic -1% to +1%); non-GAAP EPS raised to $0.27-$0.37.
- Repurchased 1.2M shares for $73.9M in Q2; $1.025B used of $1.5B authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837024007348/0001558370-24-007348-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837024007348/azta-20240508x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-007348

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer